Figure 5.
Figure 5. Blockage of erythroid differentiation by oncogenic, but not dominant-negative, H-ras. TER119- cells were purified as described in Figure 4 and infected with bicistronic retroviruses encoding hCD4 alone, H-ras wild-type (wt), oncogenic H-ras (H-ras.V12), or dominant-negative H-ras (H-ras.N17). Infected cells were cultured in vitro for 2 days as described in Figure 4, and the differentiation profiles were analyzed by flow cytometry. The left-hand panels show the density plots of all viable noninfected cells (hCD4- cells), and the right-hand panels display the density plots of all viable infected cells (hCD4+ cells) in the same culture. The percentages of TER119- cells (presented as total of R1 and R2 cells) and TER119+ cells (presented as total of R3 to R5 cells) are labeled at the bottom of each density plot.

Blockage of erythroid differentiation by oncogenic, but not dominant-negative, H-ras. TER119- cells were purified as described in Figure 4 and infected with bicistronic retroviruses encoding hCD4 alone, H-ras wild-type (wt), oncogenic H-ras (H-ras.V12), or dominant-negative H-ras (H-ras.N17). Infected cells were cultured in vitro for 2 days as described in Figure 4, and the differentiation profiles were analyzed by flow cytometry. The left-hand panels show the density plots of all viable noninfected cells (hCD4- cells), and the right-hand panels display the density plots of all viable infected cells (hCD4+ cells) in the same culture. The percentages of TER119- cells (presented as total of R1 and R2 cells) and TER119+ cells (presented as total of R3 to R5 cells) are labeled at the bottom of each density plot.

Close Modal

or Create an Account

Close Modal
Close Modal